Clinical Scorecard: Cardiometabolic Risk Factors and Cardiovascular Health in Young Adult Survivors of Cancer: Insights from Real-World Data
At a Glance
Category
Detail
Condition
Cardiometabolic risk factors and cardiovascular disease in young adult cancer survivors
Key Mechanisms
Cancer therapies induce hormonal and metabolic changes increasing cardiometabolic risk factors (diabetes, hypertension, hyperlipidaemia, obesity) which elevate cardiovascular disease risk
Target Population
Young adult cancer survivors diagnosed between ages 19 and 39 years
Care Setting
Survivorship care within healthcare systems utilizing electronic health records for longitudinal monitoring
Key Highlights
Young adult cancer survivors have higher prevalence of cardiometabolic factors compared to matched non-cancer peers.
Type 2 diabetes in survivors is associated with nearly 7-fold increased odds of myocardial infarction and over 12-fold increased odds of congestive heart failure.
Hypertension strongly correlates with congestive heart failure risk (OR ~20), underscoring the need for targeted management.
Guideline-Based Recommendations
Diagnosis
Early and routine screening for cardiometabolic risk factors (T2DM, hypertension, hyperlipidaemia, obesity) in young adult cancer survivors.
Use of electronic health records to identify and monitor cardiometabolic conditions post-cancer treatment.
Management
Integrated cardiometabolic risk assessment and prevention strategies in survivorship care.
Lifestyle interventions and targeted management of diabetes, hypertension, and lipid disorders to reduce cardiovascular risk.
Regular follow-up to detect and manage emerging cardiometabolic conditions.
Risks
Increased cardiovascular disease risk in young adult cancer survivors is driven by both cancer treatment effects and independent cardiometabolic factors.
Racial and ethnic disparities exist in cardiometabolic burden and cardiovascular outcomes, requiring tailored approaches.
Patient & Prescribing Data
Young adult cancer survivors aged 19–39 years at diagnosis with ≥2 years survivorship
Management should address both cancer treatment sequelae and prevalent cardiometabolic conditions to mitigate elevated cardiovascular disease risk.
Clinical Best Practices
Implement early screening protocols for cardiometabolic risk factors in young adult cancer survivors.
Adopt integrated care models combining oncology and cardiometabolic risk management.
Address racial and ethnic disparities through culturally sensitive interventions.
Educate survivors on lifestyle modifications to reduce cardiometabolic and cardiovascular risk.
Utilize longitudinal electronic health record data to guide personalized survivorship care.
